We are live on
!
Find out more
JGUA
John G. Ullman & Associates Portfolio holdings
AUM
$754M
1-Year Est. Return
60.05%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$735M
AUM Growth
-$32.3M
(-4.2%)
Cap. Flow
-$7.57M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
32.72%
Holding
167
New
11
Increased
20
Reduced
93
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Itron
ITRI
|
+$3.82M |
| 2 |
Merck
MRK
|
+$3.66M |
| 3 |
UCTT
Ultra Clean Holdings
UCTT
|
+$3.23M |
| 4 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$2.47M |
| 5 |
Coherent
COHR
|
+$2.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$14.7M |
| 2 |
GSK
GSK
|
+$5.1M |
| 3 |
Albemarle
ALB
|
+$4.22M |
| 4 |
Invesco Golden Dragon China ETF
PGJ
|
+$2.39M |
| 5 |
Xerox
XRX
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.04% |
| 2 | Healthcare | 21.31% |
| 3 | Industrials | 18.46% |
| 4 | Utilities | 17.61% |
| 5 | Communication Services | 8.99% |
Similar funds
HCM
FSCM
RMC
BEC
GFM
TPW
MWA
TCMI
John G. Ullman & Associates's Q3 2021 Portfolio in Review
As of Q3 2021, John G. Ullman & Associates held 167 positions worth $735M, down 4.2% from $768M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
John G. Ullman & Associates's Q3 2021 filing shows 11 new, 20 increased, 93 reduced and 7 closed positions. Its largest new stake was Ultra Clean Holdings: 68,404 shares worth $2.91M. The largest sale was Johnson & Johnson, an estimated $14.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- John G. Ullman & Associates's largest Q3 2021 buy was Ultra Clean Holdings: 68,404 shares worth $2.91M.
- John G. Ullman & Associates added most to Itron in Q3 2021, an estimated $3.82M increase.
- John G. Ullman & Associates's biggest Q3 2021 reduction was Johnson & Johnson, cutting an estimated $14.7M.
- John G. Ullman & Associates fully exited Albemarle in Q3 2021, selling an estimated $4.22M.
- John G. Ullman & Associates's ten largest holdings make up 33% of its $735M portfolio in Q3 2021.
- John G. Ullman & Associates opened 11 new positions and closed 7 in Q3 2021.
- John G. Ullman & Associates's portfolio value fell 4.2% quarter-over-quarter to $735M.
Based on John G. Ullman & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.